← Open Payments lookup

ANGELA STATHOPOULOS: Open Payments

NPI 1306096193 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$904 in 42 payments from 11 companies in 2025. Trend: 2023 $1,046 · 2024 $550 · 2025 $904

Food & beverage: $904
CompanyPaymentsAmount
Axsome Therapeutics, Inc.13$223
Teva Pharmaceuticals USA, Inc.4$116
Vanda Pharmaceuticals Inc.4$101
ABBVIE INC.4$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$76
Otsuka America Pharmaceutical, Inc.3$72
Avadel CNS Pharmaceuticals, LLC3$70
Takeda Pharmaceuticals U.S.A., Inc.2$48
E.R. Squibb & Sons, L.L.C.2$41
Neurocrine BioSciences, Inc.2$39

Products named: Auvelity, AUSTEDO XR, FANAPT, VRAYLAR, CAPLYTA, REXULTI, LUMRYZ, TRINTELLIX.

Industry payments across MI — which companies pay providers there.